Ipath Series B Etf Performance
| GRN Etf | USD 26.00 0.19 0.74% |
The etf retains a Market Volatility (i.e., Beta) of -1.01, which attests to a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning IPath Series are expected to decrease slowly. On the other hand, during market turmoil, IPath Series is expected to outperform it slightly.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in iPath Series B are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, IPath Series may actually be approaching a critical reversion point that can send shares even higher in May 2024. ...more
1 | iPath Series B Carbon ETN Stock Price Passes Below Two Hundred Day Moving Average of 29.43 - AmericanBankingNEWS | 02/28/2024 |
2 | Acquisition by Kahn Allen of 90278 shares of IPath Series at 0.36 subject to Rule 16b-3 | 03/08/2024 |
3 | AviadoBio Announces First Patient Treated in ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations | 04/15/2024 |
4 | ClearPoint Neuro si congratula con il proprio partner AviadoBio per il primo paziente trattato nello studio clinico ASPIRE-FTD, che valuta la terapia genica spe... | 04/17/2024 |
| In Threey Sharp Ratio | 0.42 |
IPath |
IPath Series Relative Risk vs. Return Landscape
If you would invest 2,428 in iPath Series B on January 26, 2024 and sell it today you would earn a total of 172.00 from holding iPath Series B or generate 7.08% return on investment over 90 days. iPath Series B is generating 0.1532% of daily returns assuming volatility of 3.0242% on return distribution over 90 days investment horizon. In other words, 26% of etfs are less volatile than IPath, and above 97% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
IPath Series Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for IPath Series' investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as iPath Series B, and traders can use it to determine the average amount a IPath Series' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0507
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GRN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.02 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.15 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average IPath Series is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IPath Series by adding it to a well-diversified portfolio.
IPath Series Fundamentals Growth
IPath Etf prices reflect investors' perceptions of the future prospects and financial health of IPath Series, and IPath Series fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IPath Etf performance.
| Price To Earning | 3.36 X | |||
| Total Asset | 122.13 M | |||
About IPath Series Performance
To evaluate iPath Series B Etf as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when IPath Series generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare IPath Etf's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand iPath Series B market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents IPath's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.The index has the objective of providing exposure to the price of carbon as measured by the return of futures contracts on carbon emissions credits from two of the worlds major emissions-related mechanisms. Ipath Series is traded on New York Stock Exchange in the United States.| iPath Series B had very high historical volatility over the last 90 days | |
| Latest headline from globenewswire.com: ClearPoint Neuro si congratula con il proprio partner AviadoBio per il primo paziente trattato nello studio clinico ASPIRE-FTD, che valuta la terapia genica sperimentale AVB-101 per la demenza frontotemporale con mutazioni GRN | |
| The fund retains all of the assets under management (AUM) in different types of exotic instruments |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iPath Series B. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
The market value of iPath Series B is measured differently than its book value, which is the value of IPath that is recorded on the company's balance sheet. Investors also form their own opinion of IPath Series' value that differs from its market value or its book value, called intrinsic value, which is IPath Series' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IPath Series' market value can be influenced by many factors that don't directly affect IPath Series' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IPath Series' value and its price as these two are different measures arrived at by different means. Investors typically determine if IPath Series is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IPath Series' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.